Correlation Between Lantheus Holdings and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Lantheus Holdings and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantheus Holdings and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantheus Holdings and Neurocrine Biosciences, you can compare the effects of market volatilities on Lantheus Holdings and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantheus Holdings with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantheus Holdings and Neurocrine Biosciences.
Diversification Opportunities for Lantheus Holdings and Neurocrine Biosciences
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lantheus and Neurocrine is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Lantheus Holdings and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Lantheus Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantheus Holdings are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Lantheus Holdings i.e., Lantheus Holdings and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Lantheus Holdings and Neurocrine Biosciences
Given the investment horizon of 90 days Lantheus Holdings is expected to under-perform the Neurocrine Biosciences. In addition to that, Lantheus Holdings is 2.45 times more volatile than Neurocrine Biosciences. It trades about -0.13 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.18 per unit of volatility. If you would invest 11,620 in Neurocrine Biosciences on August 28, 2024 and sell it today you would earn a total of 1,091 from holding Neurocrine Biosciences or generate 9.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Lantheus Holdings vs. Neurocrine Biosciences
Performance |
| Timeline |
| Lantheus Holdings |
| Neurocrine Biosciences |
Lantheus Holdings and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lantheus Holdings and Neurocrine Biosciences
The main advantage of trading using opposite Lantheus Holdings and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantheus Holdings position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Lantheus Holdings vs. Neurocrine Biosciences | Lantheus Holdings vs. Ironwood Pharmaceuticals | Lantheus Holdings vs. Alkermes Plc | Lantheus Holdings vs. Avadel Pharmaceuticals PLC |
| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |